CareFusion Corporation  

(Public, NYSE:CFN)   Watch this stock  
Find more results for cfn
+0.12 (0.20%)
Mar 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 60.07 - 60.24
52 week 37.76 - 60.36
Open 60.07
Vol / Avg. 2.01M/2.07M
Mkt cap 12.28B
P/E 25.59
Div/yield     -
EPS 2.35
Shares 204.28M
Beta 0.94
Inst. own 89%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 16.18% 10.85%
Operating margin 16.65% 16.16%
EBITD margin - 22.31%
Return on average assets 7.62% 4.58%
Return on average equity 12.80% 7.74%
Employees 16,000 -
CDP Score - -


3750 Torrey View Ct
SAN DIEGO, CA 92130-2622
United States - Map
+1-800-6848880 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company�s primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Officers and directors

Kieran T. Gallahue Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Thomas J. Leonard President - Medical Systems
Age: 46
Bio & Compensation  - Reuters
Joan B. Stafslien Executive Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Donald Abbey Executive Vice President - Quality, Regulatory and Medical Affairs
Age: 47
Bio & Compensation  - Reuters
Gordon M. La Fortune Executive Vice President - EMEA/APAC Commercial Operations and Global Infusion Disposables
Age: 57
Bio & Compensation  - Reuters
Jonathan Wygant Senior Vice President, Chief Accounting Officer, Controller
Age: 43
Bio & Compensation  - Reuters
Supratim Bose Independent Director
Age: 62
Bio & Compensation  - Reuters
Philip L. Francis Non-Employee Independent Director
Age: 67
Bio & Compensation  - Reuters
Robert F. Friel Non-Employee Independent Director
Age: 58
Bio & Compensation  - Reuters